Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Nippon India Nifty Pharma ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.02 |
Equity |
99.96 |
Trep |
0.06 |
|
|
Concentration Analysis |
Top 5 Holdings |
62.15% |
Top 10 Holdings |
80.45% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.96 |
Cash |
0.04 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.70 |
PE Ratio |
30.88 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
24.69 |
Cipla Limited |
11.11 |
DIVI LABORATORIES LTD |
9.99 |
Dr Reddys Laboratories Limited |
9.77 |
Lupin Limited |
6.59 |
Aurobindo Pharma Limited |
4.24 |
Torrent Pharmaceuticals Limited |
3.97 |
Alkem Laboratories Limited |
3.54 |
MANKIND PHARMA LIMITED |
3.41 |
Zydus Lifesciences Limited |
3.14 |
Laurus Labs Limited |
2.98 |
Glenmark Pharmaceuticals Limited |
2.76 |
IPCA Laboratories Limited |
2.64 |
Abbott India Limited |
2.27 |
Biocon Limited |
1.95 |
Gland Pharma Limited |
1.77 |
J B Chemicals and Pharma Ltd |
1.69 |
Ajanta Pharma Limited |
1.50 |
Natco Pharma Limited |
0.99 |
Granules India Limited |
0.96 |
Triparty Repo |
0.06 |
Net Current Assets |
-0.02 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|